Ovarian steroids and control of proliferation in the normal human breast.
AffiliationClinical Research Department, Christie Hospital NHS Trust, Wilmslow Road, Manchester, UK. email@example.com
MetadataShow full item record
AbstractUntil recently, there has been considerable uncertainty as to how, or even which of the ovarian steroids influence human breast luminal epithelial cell proliferation. It is important that this is known because increased proliferative activity of this particular cell population is associated with increased risk of breast cancer. Review of the available literature suggests that while oestradiol is the major steroid mitogen in pre-menopausal women, the role of progesterone becomes more significant after the menopause when oestradiol levels are reduced. Moreover, recent studies have given new insights into the mechanisms by which oestradiol and progesterone exert their effects. This knowledge may allow development of new strategies for predicting breast cancer risk or preventing the disease.
CitationOvarian steroids and control of proliferation in the normal human breast. 2001, 10 (4):273-8 Breast
- Cellular homeostasis and the breast.
- Authors: Anderson E
- Issue date: 2004 Aug 30
- Ovarian steroids and the human breast: regulation of stem cells and cell proliferation.
- Authors: Clarke RB
- Issue date: 2006 Jul 20
- Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
- Authors: Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E
- Issue date: 2005 May 18
- Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
- Authors: Sumida T, Itahana Y, Hamakawa H, Desprez PY
- Issue date: 2004 Nov 1
- The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
- Authors: Menendez JA, Oza BP, Colomer R, Lupu R
- Issue date: 2005 Jun